Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
DSGN holding history
Design Therapeutics, Inc. in every 13F filed by Prosight Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 2
- Since Q3 2023